Rick Lilley
Chief Regulatory Officer
Biochemistry
Wilson Therapeutics
Sweden
Biography
Education: B.Sc. Microbiology/Genetics and Ph.D. Molecular Genetics, Queen Mary College, University of London. Other current assignments: – Previous assignments (last five years): SVP, Head of Global Regulatory Affairs, Vertex Pharmaceuticals in Boston, USA. VP, Head of Global Regulatory Affairs, UCB Pharma in Brussels, Belgium. Holdings in the Company: 150,000 performance shares LTIP 2016 and 10,000 performance shares LTIP 2017.
Research Interest
Microbiology, Genetics, Biochemistry
